Indeed, a number of studies identified variants located in the regulatory regions of IL6 and IL6R as genetic determinants of high IL6 circulating levels in serum and tissues that have been proposed to affect the risk and progression of many different disease states (especially COVID-19, CVD and AD) [16,17,18]. The gene discussed is IL6R; the disease is COVID-19.